Hemophagocytic lymphohistiocytosis (HLH) is characterized by fever, splenomegaly, jaundice, and pathologic findings of hemophagocytosis in bone marrow or other tissues such as the lymph nodes and liver. Pleocytosis, or the presence of elevated protein levels in cerebrospinal fluid, could be helpful in diagnosing HLH. However, the pathologic diagnosis of the brain is not included in the diagnostic criteria for this condition. In the present report, we describe the case of a patient diagnosed with HLH, in whom the brain pathology, but not the bone marrow pathology, showed hemophagocytosis. As the diagnosis of HLH is difficult in many cases, a high level of suspicion is required. Moreover, the pathologic diagnosis of organs other than the bone marrow, liver, and lymph nodes may be a useful alternative.
Introduction
Hemophagocytic lymphohistiocytosis (HLH) is a systemic disease characterized by hemophagocytic syndrome accompanied by fever, hepatosplenomegaly, jaundice, cytopenia, low fibrinogen level, high ferritin level, and hypertriglyceridemia. HLH com prises two different conditions that may be indistinguishable. Familial HLH is a group caused by the mutation of the gene encoding perforin (PRF1) 1) or UNC13D gene 2) , STX11 gene 3) , or others. Secondary HLH is a group that develops as a result of strong immunologi cal activation after either infection, malignancy, or rheumatoid disorders.
According to the HLH2004 diagnostic guideline, diagnosis of HLH is done by clinical findings and laboratory results. Such diagnosis is supported by hemophagocytosis in the bone marrow or other tissues such as spleen, liver, or lymph node 4) . However, in atypical cases that do not fulfill the diagnostic criteria of HLH, histiocytes or macrophages found in the cerebrospinal fluid (CSF) can be helpful in the diagnosis. This report describes a rare HLH case who presented with prolonged fever and seizures, whose brain pathology but not bone marrow pathology showed hemophagocytosis. The institutional review board of Seoul National University Hospital approved this study (E1307039501).
Case report
A 5yearold boy visited Seoul National University Children's Hospital (SNUCH) in Korean J Pediatr 2015;58(9):358-361
August 2010 with fever for six weeks and intermittent seizure for five weeks. The patient had visited another hospital five weeks ago with fever and generalizedtonicclonic seizures. On initial CSF examination, no specific abnor malities were found: four white blood cell (WBC)/mm 3 , protein 15 mg/dL, glucose 65 mg/ dL. T2 weighted brain magnetic resonance imaging (MRI) showed high signal intensity at the right internal capsule area (Fig. 1A) . Initially he was treated with antiviral agents and antiepileptic drugs (AEDs) under the assumption of encephalitis. Neutropenia developed one week after admission, and left cervical lymph node enlargement was found three weeks after admission. Four weeks after the admission, abdominal distension developed and hepatosplenomegaly was found.
The patient was transferred to SNUCH with seizures and fever persisting for one month. Laboratory findings showed anemia and thrombocytopenia with increased reticulocyte count, elevated aspartate aminotransferase, alanine aminotransferase, and C reactive protein. Ferritin level was 15,671 ng/mL, fibrinogen level was 139 mg/dL, and triglycerides level was 285 mg/dL. Peripheral blood cell morphology showed leftshifted neutrophils, atypical lymphocytes, toxic neutrophils, and vacuolated neutrophils. EpsteinBarr virus (EBV) IgG antibody was positive, while IgM antibody was negative. His followup brain MRI done on the day of admission showed decreased size of focal lesion with high signal intensity at the anterior limb of right internal capsule (Fig.  1B) . By the second hospital day, he showed altered mentality with anisocoric pupil and sluggish light reflexes. Brain computed tomography showed severe bilateral cerebral edema and conse quent transtentorial herniation (Fig. 1C) . To control intracranial pressure, emergent craniotomy with decompressive right tem poral lobectomy was performed. Under the suspicion of HLH, bone marrow examination was done, which showed hyper cellular marrow with increased number of megakaryocytes. However, no evidence of HLH was found. EBV polymerase chain reaction was found to be negative. On brain pathology, there was perivascular and leptomeningeal lymphohistiocytic infiltration with hemophagocytosis and some red neurons with parenchymal hemorrhage. CD68 immunohistochemistry revealed perivascular and leptomeningeal histiocytic infiltration, which were consistent with HLH (Fig. 2) . There was no mutation detected on the gene analysis of PRF1 and UNC13D. On the basis of clinical features, the patient was diagnosed with HLH. Hemophagocytosis found in the brain biopsy specimen supported such diagnosis. The etiology is not confirmed but secondary HLH might be more possible given his age and clinical course.
Under the diagnosis of HLH, the patient was treated with chemotherapy of HLH2004 regimen 4) suggested by the Histiocyte Society which is based on etoposide, dexamethasone, cyclospo rine A, and intrathecal chemotherapy with methotrexate and prednisolone in selected patients. In addition, CSF analysis and intrathecal chemotherapy was done at two days after the initia tion of the HLH2004 regimen due to brain involvement of HLH. CSF findings showed one WBC/mm 3 , and the protein level of CSF was 126 mg/dL. Intrathecal methotrexate and hydrocortisone were administered four times in total. In the last followup CSF analysis (done after the 4th intrathecal chemotherapy), CSF pro tein level was decreased to 93 mg/dL and WBC level was 2/mm 3 . After eight weeks of initial therapy, his mentality improved but left side hemiplegia persisted with motor power grade III. Seizures were controlled with AEDs during the chemotherapy. There was no evidence of HLH reactivation for over 28 months after completion of chemotherapy, and his ferritin improved significantly (Fig. 3) . Now he is being followed up with AEDs for seizure controls and his left hemiplegia is much improved.
Discussion
Until now, there was one report about neuropathologic findings of central nervous system (CNS)involved HLH patients con firmed with autopsy specimen 5) . In addition, there was a report of HLH which involved only CNS with pathological confirmation, without other systemic symptoms 6) . Most recently, there was a report of two CNSinvolved HLH cases in Korea 7)
. In current case, HLH was diagnosed on the basis of clinical features and lab findings. The unique finding of this study was that bone marrow pathology did not show the features of HLH, but the pathology of brain showed hemophagocytosis, supporting the diagnosis. The patient's initial ferritin level was 15,671 ng/mL, in accordance with the result of a recent report which showed ferritin levels above 10,000 ng/mL are specific and sensitive for HLH 8) . Elevated protein level of CSF also supported the diagnosis of HLH 9)
. On the basis of the present report, we suggest that the dia gnostic criteria of HLH2004 may need some updating. In some cases, the diagnostic criteria cannot be fulfilled even if HLH is strongly suspected clinically. A recent study showed that hemo phagocytosis of bone marrow specimen has 83% sensitivity and 60% specificity only 10) , and another report showed HLH diag nosed after repetitive bone marrow biopsy 11) . Furthermore, some laboratory exams (e.g., soluble CD25 and NKcell activity) are not available in many hospitals, making the diagnosis more difficult. In these circumstances, if hemophagocytosis is confirmed at organs other than bone marrow, liver and lymph node, it can be helpful in the diagnosis of HLH. HLH is known to be a fatal dis ease that has a high mortality rate if the diagnosis is delayed. Prompt recognition and early treatment are significant for HLH patient recovery. Therefore, the confirmation of hemophagocy tosis in other organs may be helpful in the diagnosis of HLH when other clinical findings support.
CNS involvement is common in HLH, and the manifestation is highly variable: seizure, hemiplegia or tetraplegia, ataxia, cranial nerve palsy, signs of increased intracranial pressure, and coma. Thus, when a patient shows unexplained neurologic manifesta tions, HLH should also be considered in the differential diagnosis. However, reports showed that some HLH patients do not have neurological symptoms or signs but do have neuroradiological abnormal findings. These findings imply that neuroradiological abnormality may precede apparent clinical neurological manife stations 12) . HLH with CNS involvement has been reported in up to 50% of patients, and they have worse outcome with a poorer 5year survival rate 13) . Therefore, evaluation for CNS should be done when HLH is diagnosed. CSF analysis is included in the 
